Tardugno Michael H 4

What Happened

• Michael H. Tardugno, Executive Chairman and Director of Imunon, received an award of 4,410 shares on July 2, 2026. The shares were recorded at $1.91 each for a total value of $8,423. This transaction is an award/grant (code A) — not an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-02
• Filing date (Form 4): 2026-07-07
• Transaction type/code: Award/Grant (A)
• Shares received: 4,410
• Price per share recorded: $1.91
• Total value reported: $8,423
• Footnote: F1 — stock granted in lieu of cash for base salary
• Shares owned after transaction: Not specified in the provided filing
• Timeliness: Filing date is 5 days after the transaction date; Form 4s are typically due within 2 business days, so investors may want to check the full filing for any timeliness notes.

Context

• Grants issued in lieu of cash salary are a routine form of executive compensation and do not necessarily indicate a bullish or bearish signal by the insider. The value here is modest (~$8.4K). For trading signals, outright purchases are generally more informative; continue to monitor future Form 4s for any sales or open-market buys by the insider.